Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A retinoic acid resistant HL-60 cell clone sensitive to N-(4-hydroxyphenyl) retinamide-mediated clonal growth inhibition.

Leukemia & lymphoma - 1 Mar 1995

Brigati C, Ferrari N, Megna M, Roncella S, Cutrona G, Tosetti F, Vidali G

Abstract excerpt

Among the Retinoic Acid (RA) derivatives, retinamides, and in particular N-(4-hydroxyphenyl) retinamide (4-HPR), are currently being investigated in selected cases of cancer chemoprevention. The cellular target range, however, seems to be limited, as cells of hemopoietic origin are virtually incapable of terminal differentiation upon addition of the compound. We have reconsidered the effect of 4-HPR on HL-60...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Differentiation
Share to Cell Division

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clone Cells

Share to Drug Resistance

Share to Flow Cytometry

Share to Phenotype

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 7773156
DOI: 10.3109/10428199509051719

Genes

HPR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A retinoic acid resistant HL-60 cell clone sensitive to N-(4-hydroxyphenyl) retinamide-mediated clonal growth inhibition.PMID 7773156Read ↗

4-Oxo-Fenretinide, a Recently Identified Fenretinide Metabolite, Induces Marked G2-M Cell Cycle Arrest and Apoptosis in Fenretinide-Sensitive and Fenretinide-Resistant Cell LinesSemantic proximity Read ↗

Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis.Semantic proximity Read ↗

A unique carboxy-terminus truncation mutant of the retinoic acid receptor alpha gene associated with a variant marker chromosome in a retinoic acid resistant HL-60 subline.Semantic proximity Read ↗

Mutation in the ligand-binding domain of the retinoic acid receptor alpha in HL-60 leukemic cells resistant to retinoic acid and with increased sensitivity to vitamin D3 analogs.Semantic proximity Read ↗

Retinoic-acid-resistant neuroblastoma cell lines show alteredMYC regulation and high sensitivity to fenretinideSemantic proximity Read ↗

Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells.Semantic proximity Read ↗

Radicicol, an agent inducing the reversal of transformed phenotypes of src-transformed fibroblasts.Semantic proximity Read ↗

Altered expression of cell cycle related genes including c-myb in a subclone of HL-60 that exhibits reversible differentiation.Semantic proximity Read ↗

Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha).Semantic proximity Read ↗

Growth inhibition and induction of specific hepatic phenotype expression by retinoic acid in HEPG2 cells.Semantic proximity Read ↗

Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.Semantic proximity Read ↗

Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.